This measure captures the proportion of acute ischemic stroke patients who arrive at this hospital within 2 hours of time last known well for whom IV t-PA was initiated at this hospital within 3 hours of time last known well.
This measure is a part of a set of eight nationally implemented measures that address stroke care (STK-1: Venous Thromboembolism (VTE) Prophylaxis, STK-2: Discharged on Antithrombotic Therapy, STK-3: Anticoagulation Therapy for Atrial Fibrillation/Flutter, STK-5: Antithrombotic Therapy By End of Hospital Day 2, STK-6 Discharged on Statin Medication, STK-8: Stroke Education, and STK-10: Assessed for Rehabilitation) that are used in The Joint Commission’s Disease-Specific Care stroke certification programs.
Acute ischemic stroke patients for whom IV thrombolytic therapy was initiated at this hospital within 3 hours (less than or equal to 180 minutes) of time last known well.
Denominator
1.15 Denominator
Acute ischemic stroke patients whose time of arrival is within 2 hours (less than or equal to 120 minutes) of time last known well.
Exclusions
Exclusions
• Less than 18 years of age • Length of Stay > 120 days • Enrolled in clinical trials related to stroke • Admitted for elective carotid intervention • Time last known well to arrival in the emergency department greater than 2 hours • Documented reason for extending the initiation of IV thrombolytic • Documented reason for not initiating IV thrombolytic
Measure Record
Most Recent Endorsement Activity
Endorsed Neurology Project 2015-2016
Initial Endorsement
Last Updated
Removal Date
Point of Contact
Steward Organization
The Joint Commission
Steward POC email
jalban@jointcommission.org
Steward Organization Copyright
No royalty or use fee is required for copying or reprinting this manual, but the following are required as a condition of usage: 1) disclosure that the Specifications Manual is periodically updated, and that the version being copied or reprinted may not be up-to-date when used unless the copier or printer has verified the version to be up-to-date and affirms that, and 2) users participating in Joint Commission accreditation, including ORYX® vendors, are required to update their software and associated documentation based on the published manual production timelines.
Public Comments